Williams Jones Wealth Management, Llc. Regenerx Biopharmaceuticals Inc Transaction History

Williams Jones Wealth Management, Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.16 - $0.29 $32,000 - $57,999	-200,000 Reduced 95.24%	10,000 $2,000
Q4 2020 Feb 16, 2021	BUY	$0.38 - $0.6 $3,800 - $6,000	10,000 Added 5.0%	210,000 $93,000
Q4 2019 Feb 14, 2020	BUY	$0.13 - $0.18 $7,800 - $10,800	60,000 Added 42.86%	200,000 $28,000
Q3 2019 Nov 14, 2019	BUY	$0.13 - $0.18 $18,200 - $25,200	140,000 New	140,000 $22,000

Ticker RGRX
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,550,000
Description
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.